Get your paper

Healthcare news, Nov 16 to 22, 2026

The 15 healthcare stories that mattered most to marketing teams so far this week, picked from 7 outlets and ranked by impact. Each one says why it matters and links to the original reporting.

The week in healthcare

  1. Apple releases health AI usage study app with OpenEvidence

    Marketing teams in health‑tech and consumer brands can use the study’s early findings to shape messaging around AI safety and trust. They should monitor the results and consider aligning their own AI‑health offerings with the criteria Apple is testing.

    TechCrunch AI · also The Times of India, Healthcare Dive, PYMNTS

  2. STAT+: FDA approves new breast cancer drug, providing new option for some patients, boost for Roche

    Rules like this change what marketing can claim, collect or run. Worth a check with legal and a plain-English explainer for customers.

    STAT

  3. STAT+: Federal judge issues final ruling blocking U.S. plan to limit visa length for grad students, postdocs

    Rules like this change what marketing can claim, collect or run. Worth a check with legal and a plain-English explainer for customers.

    STAT

  4. STAT+: In a win for MAHA, FDA creates new regulatory category for the supplement NAC

    Rules like this change what marketing can claim, collect or run. Worth a check with legal and a plain-English explainer for customers.

    STAT

  5. STAT+: Expert warns of battleground over global access to newer GLP-1 drugs for obesity

    A move in your market that customers and prospects will hear about. Worth checking against your positioning before someone asks.

    STAT

  6. STAT+: NIAID acting head John Powers III appointed as the permanent director

    A move in your market that customers and prospects will hear about. Worth checking against your positioning before someone asks.

    STAT

  7. Summit shares fall as FDA rejects closely watched PD-1/VEGF drug

    Rules like this change what marketing can claim, collect or run. Worth a check with legal and a plain-English explainer for customers.

    BioPharma Dive

  8. J&J bets $2.2B on Ollin’s vision loss drug

    A move in your market that customers and prospects will hear about. Worth checking against your positioning before someone asks.

    BioPharma Dive

  9. STAT+: Biotech’s rebound isn’t lifting all boats equally

    A move in your market that customers and prospects will hear about. Worth checking against your positioning before someone asks.

    STAT

  10. STAT+: Suing Joe the Plumber and Microsoft, and diminishing raises

    A move in your market that customers and prospects will hear about. Worth checking against your positioning before someone asks.

    STAT

  11. CMS gives states another 6 months to implement Medicaid work requirements

    A move in your market that customers and prospects will hear about. Worth checking against your positioning before someone asks.

    Healthcare Dive

  12. MiniMed gets FDA nod for tubeless insulin pump

    Rules like this change what marketing can claim, collect or run. Worth a check with legal and a plain-English explainer for customers.

    MedTech Dive

  13. Health AI spend doubles as providers invest in clinical copilots, front-office AI

    Technology your buyers use to find and judge you is changing. Worth knowing before it shows up in their questions.

    Healthcare Dive

  14. Medtronic to buy Contego Medical for $380M

    A move in your market that customers and prospects will hear about. Worth checking against your positioning before someone asks.

    MedTech Dive

  15. CVS white paper aims to pressure drugmakers to lower GLP-1 prices

    A move in your market that customers and prospects will hear about. Worth checking against your positioning before someone asks.

    Healthcare Dive